BACKGROUND: An epidemiological study of Streptococcus pneumoniae nasopharyngeal carriage in healthy children was carried out five years after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13). OBJECTIVES: Study the impact of pediatric vaccination with PCV13, and other associated epidemiological factors on the status of nasopharyngeal carriage, the circulating pneumococcal serotypes, and the antibiotic susceptibility to more frequently used antibiotics. METHODS: A multi-center study was carried out in Primary Health Care, which included 1821 healthy children aged 1 to 4 years old. All isolates were sent to the Spanish Pneumococcal Reference Laboratory for serotyping and antimicrobial susceptibility testing. RESULTS: At least one dose of PCV13 had been received by 71.9% of children and carriage pneumococcal prevalence was 19.7%. The proportion of PCV13 serotypes was low (14.4%), with an observed predominance of non-vaccine serotypes, 23B, 11A, 10A, 35B/F, and 23A were the five most frequent. A high rate of resistance to penicillin, erythromycin, and trimethoprim sulfamethoxazole was found. CONCLUSIONS: A low proportion of PCV13 serotypes were detected, confirming the impact of pediatric vaccination for reducing the serotypes vaccine carriage. High resistance rates to clinically important antibiotics were observed.
BACKGROUND: An epidemiological study of Streptococcus pneumoniae nasopharyngeal carriage in healthy children was carried out five years after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13). OBJECTIVES: Study the impact of pediatric vaccination with PCV13, and other associated epidemiological factors on the status of nasopharyngeal carriage, the circulating pneumococcal serotypes, and the antibiotic susceptibility to more frequently used antibiotics. METHODS: A multi-center study was carried out in Primary Health Care, which included 1821 healthy children aged 1 to 4 years old. All isolates were sent to the Spanish Pneumococcal Reference Laboratory for serotyping and antimicrobial susceptibility testing. RESULTS: At least one dose of PCV13 had been received by 71.9% of children and carriage pneumococcal prevalence was 19.7%. The proportion of PCV13 serotypes was low (14.4%), with an observed predominance of non-vaccine serotypes, 23B, 11A, 10A, 35B/F, and 23A were the five most frequent. A high rate of resistance to penicillin, erythromycin, and trimethoprim sulfamethoxazole was found. CONCLUSIONS: A low proportion of PCV13 serotypes were detected, confirming the impact of pediatric vaccination for reducing the serotypes vaccine carriage. High resistance rates to clinically important antibiotics were observed.
Authors: César García-Vera; María Ángeles Ruiz Andrés; Teresa Arana Navarro; Isabel Moneo Hernández; José Antonio Castillo Laita; Rosa Macipe Costa; María José Revillo Pinilla Journal: Med Clin (Barc) Date: 2011-04-22 Impact factor: 1.725
Authors: Grace M Lee; Ken Kleinman; Stephen I Pelton; William Hanage; Susan S Huang; Matthew Lakoma; Maya Dutta-Linn; Nicholas J Croucher; Abbie Stevenson; Jonathan A Finkelstein Journal: J Pediatric Infect Dis Soc Date: 2013-10-03 Impact factor: 3.164
Authors: Camelia Savulescu; Pavla Krizova; Agnes Lepoutre; Jolita Mereckiene; Didrik F Vestrheim; Pilar Ciruela; Maria Ordobas; Marcela Guevara; Eisin McDonald; Eva Morfeldt; Jana Kozakova; Emmanuelle Varon; Suzanne Cotter; Brita A Winje; Carmen Munoz-Almagro; Luis Garcia; Jesus Castilla; Andrew Smith; Birgitta Henriques-Normark; Lucia Pastore Celentano; Germaine Hanquet Journal: Lancet Respir Med Date: 2017-03-27 Impact factor: 30.700
Authors: Sara de Miguel; Mirian Domenech; Fernando González-Camacho; Julio Sempere; Dolores Vicioso; Juan Carlos Sanz; Luis García Comas; Carmen Ardanuy; Asunción Fenoll; Jose Yuste Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079
Authors: Shamez N Ladhani; Sarah Collins; Abdelmajid Djennad; Carmen L Sheppard; Ray Borrow; Norman K Fry; Nicholas J Andrews; Elizabeth Miller; Mary E Ramsay Journal: Lancet Infect Dis Date: 2018-01-26 Impact factor: 25.071
Authors: Brayan E Gonzales; Erik H Mercado; Maria Pinedo-Bardales; Noemi Hinostroza; Francisco Campos; Eduardo Chaparro; Olguita Del Águila; María E Castillo; Andrés Saenz; Isabel Reyes; Theresa J Ochoa Journal: Front Cell Infect Microbiol Date: 2022-05-09 Impact factor: 6.073
Authors: Feroze Ganaie; Karsten Maruhn; Chengxin Li; Richard J Porambo; Pernille L Elverdal; Chitrananda Abeygunwardana; Mark van der Linden; Jens Ø Duus; Carmen L Sheppard; Moon H Nahm Journal: J Clin Microbiol Date: 2021-06-18 Impact factor: 5.948